Effect of Intravenous Immunoglobulin G on the Deposition of Immunoglobulin G and C3 onto Type III Group B Streptococcus and Escherichia coli K1

Journal of Perinatology

Volumn 16, Issue 5, 1996, Pages 346-351

  Lassiter, Herbert A ^a   Robinson, Tonya W ^a   Brown, Mark S ^b   Hall, David C ^b   Hill, Harry R ^c   Christensen, Robert D ^c  

^a University of Louisville School of Medicine   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BACTEREMIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; PSEUDOMONAS AERUGINOSA; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; STREPTOCOCCACEAE; STREPTOCOCCUS INFECTION;

ADULT; BACTEREMIA; COMPLEMENT C3; DOUBLE-BLIND METHOD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MALE; PSEUDOMONAS AERUGINOSA; RADIOIMMUNOASSAY; REFERENCE VALUES; STREPTOCOCCACEAE; STREPTOCOCCAL INFECTIONS;

EID: 0030225556     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Baker CJ, Melish ME, Hall RT, Casto DT, Vasan U, Givner LB, and the Multicenter Group for the Study of Immune Globulin in Neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992;327:213-9.
2. Wilson CB. Developmental immunology and role of host defenses in neonatal susceptibility. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 3rd ed. Philadelphia: WB Saunders, 1990:17-67.
3. Stevens P, Huang S, Welch WK, Young LS. Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity. J Immunol 1978;121:2174-80.
4. Edwards MS, Nicholson-Weller A, Baker CJ, Kasper DL. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B streptococcus. J Exp Med 1980;151:1275-87.
5. Fischer GW. Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies. J Clin Immunol 1990;10(suppl):40S-6S.
6. Campbell JR, Baker CJ, Edwards MS. Deposition and degradation of C3 on type III group B streptococcus. Infect Immun 1991;59:1978-83.
7. Lassiter HA, Christensen RD, Parker CJ. Immunological regulation of E. coli K1 by serum from neonatal rats is enhanced following intraperitoneal administration of human IgG. J Infect Dis 1989;159:518-25.
8. Christensen RD, Brown MS, Hall DC, Lassiter HA, Hill HR. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. J Pediatr 1991;118:606-14.
9. Manroe BL, Weinburg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease: I - reference values for neutrophilic cells. J Pediatr 1979;95:89-98.
10. Givner LB, Edwards MS, Anderson DC, Baker CJ. Immune globulin for intravenous use: enhancement of in vitro opsonophagocytic activity of neonatal serum. J Infect Dis 1985;151:217-20.
11. Lassiter HA, Speranza MJ, Hall RT, Meade V, Christensen RD, Parker CJ. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin. J PERINATOL 1990;10:27-31.
12. Bruce MC, Baley JE, Medvik KA, Berger M. Impaired surface membrane expression of C3bi but not C3b receptors on neonatal neutrophils. Pediatr Res 1987;21:306-11.
13. Smith JB, Campbell DE, Ludomirsky A, et al. Expression of the complement receptors CR1 and CR3 and the type III Fc receptor on neutrophils from newborn infants and from fetuses with Rh disease. Pediatr Res 1990;28:120-6.
14. Lassiter HA. Intravenous immunoglobulin in the prevention and treatment of neonatal bacterial sepsis. Adv Pediatr 1992;39:71-99.
15. Yang KD, Bathras JM, Shigeoka AO, James J, Pincus SH, Hill HR. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy. J Infect Dis 1989;159:701-7.
16. Zach TL, Hostetter MK. Biochemical abnormalities of the third component of complement in neonates. Pediatr Res 1989;26:116-20.
17. Notarangelo LD, Chirico G, Chiara A, et al. Activity of the classical and alternative pathways of complement in preterm and small for gestational age infants. Pediatr Res 1984;18:281-5.